Technical Appendix
Technical Appendix Table 1 contains detailed information on all travel-associated hospitalizations included in the present study by region of travel.
In the description of causes of hospitalization acquired in a single destination country in Technical Appendix Table 2 , we included travelers for whom the country of disease acquisition was determinable (634/722, 88%). We excluded countries in which <5 hospitalizations were recorded during the study years. Only countries with consistent entries reporting and ≥5 hospitalizations are shown (Technical Appendix Table 2 ).
We extracted the total number of Israeli citizen entries for each destination country during 2004-2015 from the United Nations World Tourism Organization dataset (1) .In some countries, reporting of Israeli entries was inconsistent (i.e., there were years with missing entry data). Countries with consistent entry reporting were defined as countries which reported the number of Israeli citizen entries during all years or at least 11 out of 12 years included in the study.We included all countries with ≥5 hospitalizations regardless of whether they consistently reported to the United Nations World Tourism Organization; and when reporting was inconsistent, we denote as non-applicable (NA) for number of entries. ‡One patient returning from Asia with malaria had a coinfection with both P. falciparum and P. vivax. In this case, we decided to list the patient under P. falciparum. §"Other" comprises both Oceania (n = 6) and cases whose exact region of infection was undetermined (n = 26).
